Rao X Q, Yu R C, Zhang J H
Dept. of Oncology, Beijing Hospital of TCM.
Zhong Xi Yi Jie He Za Zhi. 1991 Apr;11(4):218-9, 197.
242 cases of cancer patients with spleen-deficiency syndrome have been studied. It has been found that some immune indexes such as phagocytic activities of macrophages, lymphocytic transformation rate, E-rosette forming rate, Th-cell in T cell subgroup, the NK cell cytotoxicity and combining ability, of cancer patients with spleen-deficiency syndrome were lower than those of normal donor (P less than 0.001 or 0.002). After the patients were treated with sheng xue tang (SXT), the immune indexes above mentioned have been increased significantly. These results suggest that SXT can improve the cell-mediated immune function, therefore, it can strengthen the anticancer ability of the patient, prolong the survival period of some patients.
对242例癌症脾虚证患者进行了研究。发现癌症脾虚证患者的一些免疫指标，如巨噬细胞吞噬活性、淋巴细胞转化率、E玫瑰花结形成率、T细胞亚群中的Th细胞、NK细胞细胞毒性及结合能力等，均低于正常供者（P＜0.001或0.002）。患者用升血汤（SXT）治疗后，上述免疫指标有明显提高。这些结果提示，SXT能改善细胞介导的免疫功能，从而增强患者的抗癌能力，延长部分患者的生存期。
